Despite our most vigorous efforts, prostate cancer remains the second leading ... enzyme gene expression in CRPC? In addition, mechanisms underlying the post-transcriptional regulation of these ...
Northwestern Medicine investigators have discovered new molecular mechanisms underlying DNA repair dysregulation in prostate cancer cells, findings that may inform the development of new targeted ...
Yibin Kang, a professor in the Department of Molecular Biology, discussed new breast cancer research in his lab.
The identification of new drug resistance mechanisms and prostate cancer molecular subtypes based on genomic and proteomic analysis, as well as prognostic and predictive biomarkers, may further ...
Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.
Prostate cancer continues ... or targeted molecular therapies. The emergence of CRPC marks a significant turning point in the disease’s progression, and understanding the mechanisms behind ...
The 'seed and soil' theory may be applied to prostate cancer (PC) brain metastasis (BM) development, with the possibility of having a dormant period. The clinical mechanism of true BM development ...
Digital histopathology for clinically applicable biomarker discovery We are interested in exploring how hypoxia-related mechanisms of prostate ... upon molecular pathways in the tumour cells. In ...
Intrigued by VPS34’s role in prostate cancer, Trotman wondered if MSB could tackle another ... He plans to delve deeper into the molecular mechanisms behind pro-oxidant supplements and triaptosis, ...
(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Poster Session A: Prostate Cancer. Dr. Moein Moradpour ...
Harvard Health Publishing on MSN4mon
CAR-T immunotherapy for prostate cancer?
The engineered cells are studded with proteins called chimeric antigen receptors (CARs) that bind to specific molecular targets ... with metastatic prostate cancer that was no longer responding ...